Genetic immunization
US5830876A · kind A · utility
117Cited by
7References
17Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 30, 1995 |
| Grant date | Nov 3, 1998 |
| Priority date | — |
| Expiry date | May 30, 2015 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/975
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of immunizing an individual against pathogen is disclosed. Also disclosed is a method of treating an individual who has a hyperproliferative disease, or of treating an individual who is infected by a pathogen. Specifically, the individual is injected with bupivacaine along with DNA in an expressible form, the DNA encoding an antigen. The encoded antigen can be from a protein from the pathogen or from a protein associated with the hyperproliferative disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.